4/A//SEC Filing
BioPharmX Corp 4/A
Accession 0001424422-16-000036
CIK 0001504167operating
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 7:34 PM ET
Size
8.2 KB
Accession
0001424422-16-000036
Insider Transaction Report
Form 4/AAmended
BioPharmX Corpbpmx
Morlock Stephen
Director
Transactions
- Purchase
Common stock
2016-11-28$0.35/sh+428,571$150,000→ 543,956 total - Purchase
Warrants to purchase common stock
2016-11-28+321,428→ 321,428 totalExercise: $0.35→ Common stock (321,428 underlying)
Holdings
- 251,071(indirect: By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03)
Common stock
Footnotes (4)
- [F1]Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03
- [F2]Securities are purchased as a unit, priced at $0.35 per unit, which consists of one share of common stock and one warrant to purchase 0.75 of a share of common stock.
- [F3]Warrants become exercisable upon the later of the one year anniversary from issuance and receiving stockholder approval to increase the number of authorized shares of common stock.
- [F4]Warrants expire 7 years from the exercisability date.
Documents
Issuer
BioPharmX Corp
CIK 0001504167
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001504167
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 7:34 PM ET
- Size
- 8.2 KB